AlfaGene Bioscience, Inc.
AlfaGene is an innovative biotechnology company established in 2007, in order to take advantage of its own proprietary novel gastrointestinal (GI) stem cell technology to isolate and establish long term human adult stem cell lines from human adult GI tissue samples, derive primary non-transformed epithelial lineages from these adult stem cell lines, and create the only stem cell and non-transformed primary epithelial cell derived model of each segment of the entire GI tract. Utilizing this unique technology, AlfaGene can create a system of paired adult stem and epithelial cells derived from disease initiating stem cells and their unaffected normal counterpart from the same individual’s GI tissue.
Any
GI disease can be targeted; whether
adenocarcinoma malignant cancer cells in
the case of colon cancer or
esophageal cancer, or cells affected by Ulcerative Colitis, Crohn's
Disease... Thus, allowing
AlfaGene
to directly compare and identify cellular, molecular, and genetic
differences (biomarkers) between disease affected
and normal unaffected GI cells. This technology also enables
AlfaGene
to provide a unique superior cellular platform for drug discovery &
testing with previously unattainable accuracy, relevancy, and
reproducibility, as well as, reduce variation and background than
previous methods. Furthermore,
AlfaGene's
technology, will enable us to provide personalized stem cell therapy
by treating an individual with their own stem cells - thus avoiding
any immunological reactivity issues.
AlfaGene's Research Divisions
AlfaGene's research and commercialization efforts are currently contained within three divisions in order to efficiently maximize research, capitalization, and commercialization efforts with regards to the company's unique technology. Furthermore, an additional four sub-divisions exist within AlfaGene's Biomarker Discovery and Development Division.
- Biomarker
Discovery
and Development
- Colon Cancer (CC) Biomarkers
- Ulcerative Colitis (UC) Biomarkers
- Crohn's Disease (CD) Biomarkers
- Esophageal Cancer (EC) and Barett's Esophagus Biomarkers
- GI Model for Drug Discovery and Development
- Personalized Regenerative Medicine Via Stem Cell Therapy
Facilities
Laboratory
12 Industrial Road
Fairfield, NJ 07004
Phone: (732)469-5631
FAX: (732)560-0266
The Laboratory Facility consists of 6,000 square feet of combined laboratory and office space, stocked with state of the art laboratory equipment and a 120 square foot enclosed secured tissue culture room. At this time the company envisions leasing and occupying an additional 15,000 square feet which is currently available at this site.
Corporate Office
20 Corrielle Street
Fords, NJ 08863
Phone: (732)738-7340
FAX: (732)738-7343
Email: info@alfagenebioscience.com
Web: www.alfagenebioscience.com